Business Wire

GSMA: 5G At Risk If Mobile Operators Don’t Get Access to the Right Spectrum

Jaa

The successful rollout of ultra-fast 5G services relies on timely access to the right amount and type of spectrum in the next year, warns the GSMA in an industry position released today. As the race to launch 5G services intensifies, the GSMA highlights the need for governments, regulators and the mobile industry to work together to deliver widespread coverage, and the full potential of 5G for everyone.

According to the ‘GSMA Public Policy Position on 5G Spectrum,’ governments around the world have started to auction spectrum for 5G networks, but variations in how much spectrum has been assigned, the onerous conditions imposed – and the cost of access to that spectrum – means the speed, reach and quality of 5G services could vary dramatically between countries. Early adopter countries will be the first to realise the significant benefits of 5G – from fibre-like mobile broadband speeds and smarter cities to autonomous cars and digitised factories – and stand to reap important socio-economic benefits including GDP growth. GSMA Intelligence forecasts that there will be 1.3 billion 5G connections by 2025, but this will be dependent on operators gaining access to sufficient spectrum.

“Operators urgently need more spectrum to deliver the endless array of services that 5G will enable - our 5G future depends heavily on the decisions governments are making in the next year as we head into WRC-19,” said Brett Tarnutzer, Head of Spectrum, GSMA. “Without strong government support to allocate sufficient spectrum to next generation mobile services, it will be impossible to achieve the global scale that will make 5G affordable and accessible for everyone. There is a real opportunity for innovation from 5G, but this hinges on governments focusing on making enough spectrum available, not maximising auction revenues for short term gains.”

The GSMA outlines several key considerations for governments and regulators, including:

1. 5G needs wider frequency bands to support higher speeds and larger amounts of traffic. Regulators that make available 80-100 MHz of spectrum per operator in prime 5G mid-bands (e.g. 3.5 GHz) and around 1 GHz per operator in vital millimeter wave bands (i.e. above 24 GHz), will best support the very fastest 5G services.

2. 5G needs spectrum within three key frequency ranges to deliver widespread coverage and support all use cases:

  • Sub-1GHz spectrum to extend high-speed 5G mobile broadband coverage across urban, suburban and rural areas and to help support Internet of Things (IoT) services
  • Spectrum from 1-6 GHz to offer a good mix of coverage and capacity for 5G services
  • Spectrum above 6 GHz for 5G services such as ultra-high-speed mobile broadband

3. It is essential that governments support the 26 GHz, 40 GHz (37-43.5 GHz) and 66-71 GHz bands for mobile at WRC-19. A sufficient amount of harmonised 5G spectrum in these bands is critical to enabling the fastest 5G speeds, low-cost devices and international roaming and to minimising cross-border interference.

4. Governments and regulators should avoid inflating 5G spectrum prices (e.g. setting high auction reserve prices) as they risk limiting network investment and driving up the cost of services.

5. Regulators should avoid setting aside spectrum for verticals in key mobile spectrum bands; sharing approaches, such as leasing, are better options where vertical industries require access to spectrum.

“Governments and regulators have a major role to play in ensuring that consumers get the best outcome from 5G,” added Tarnutzer. “Once spectrum is allocated to mobile at WRC, licensing that spectrum at a national level, as history has shown, can take up to 10 years. Therefore, it is essential that governments take the right action now.”

The ‘GSMA Public Policy Position on 5G Spectrum’ is available here .

Further information on the GSMA’s position on WRC-19 can be viewed here .

-ENDS-

About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

Media Contacts
For the GSMA
Alia Ilyas
+44 (0)7970 637622
ailyas@gsma.com
or
GSMA Press Office
pressoffice@gsma.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58Tiedote

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs

Kalray Joins Autoware Foundation as Founding Premium Member14.12.2018 10:18Tiedote

Kalray (Euronext Growth Paris – ALKAL), a pioneer in processors for new intelligent systems, today announced it has joined the Autoware Foundation as a founding premium member. The formation of Autoware was formally announced on December 10, 2018 with a mission of facilitating the deployment of Autoware open-source projects enabling self-driving mobility. The Autoware Foundation creates synergies between corporate development and academic research, enabling autonomous driving technology for everyone. "We are glad to have the presence of Kalray as a premium member of the Autoware Foundation. Having highly efficient hardware solutions supporting autonomous driving software is instrumental to boost the deployment of Autoware in the market!" said Shinpei Kato, member of the Board of Directors for Autoware. Autonomous driving demands massive processing power, low power consumption and bulletproof safety and security to handle critical functions like AI processing, acceleration of perception

IDEMIA Provides Subscription Management Platform to dtac in Thailand to Offer eSIM Connected Watches to All Its Subscribers.14.12.2018 06:30Tiedote

IDEMIA, the global leader in Augmented Identity, has been selected by dtac, the leading mobile operator in Thailand, to offer connectivity on eSIM connected watches. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213005934/en/ Credits : IDEMIA IDEMIA’s Subscription Management platform (or remote SIM provisioning) is the technology that remotely connects the embedded SIM of a smartwatch to dtac’s network without inserting a physical SIM card. Indeed, the IDEMIA Subscription Manager is a server which securely manages the lifecycle of mobile subscriptions and profiles for eSIM-ready consumer devices and wearables. This solution is compliant with the latest GSMA (Global System for Mobile Communications Association) standards to ensure global interoperability and, thanks to the scalability of the platform, the operator will be able to serve up to millions of customers during peak times. dtac subscribers now have the possibilit

CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer13.12.2018 20:46Tiedote

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending an additional indication to include rucaparib as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. EC approval is anticipated in the first quarter of 2019. Once approved, Rubraca’s indication will expand beyond its initial Marketing Authorization in Europe granted in May 2018 for adult patients with platinum-sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum-based chemotherapy, and who are unable to tolerate further platinum

Dole Food Company Sells Fresh Cut Business in Sweden and Finland13.12.2018 20:00Tiedote

Dole Food Company, Inc., announced today an agreement to sell Saba Fresh Cuts AB and Saba Fresh Cuts OY to BAMA International. Saba Fresh Cuts AB—with production facility in Helsingborg Sweden—and Saba Fresh Cuts OY—with production facility in Espoo Finland—are producers of washed and ready-to-eat salads. The companies prepare and sell various fresh-cut salads and vegetables to the retail and foodservice industry in Sweden, Denmark, Finland, Germany and the Baltic States. The sale of Saba Fresh Cuts AB was a necessary condition of the European Commission’s approval of the investment by Total Produce into Dole in July 2018. “I am very pleased with the outcome of this sale in meeting the EU’s requirement,” said Mr. Johan Linden, President and Chief Executive Officer of Dole Food Company, “and I am confident that Saba Fresh Cuts will be in good hands under BAMA’s ownership.” "We are pleased to announce this agreement with Dole for Saba Fresh Cuts. Convenience products and ready-to-eat sal

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme